Amorepacific (090430) plans to reach 15 trillion won (approximately $11.2 billion) in group revenue by 2035, with derma beauty and hair care serving as new growth pillars. At its 2026 Investor Day at its headquarters in Yongsan, Seoul, on the 11th, the company said it would accelerate existing flagship brands while developing derma beauty, clinical skincare, and hair care as global core products. Aestura and Illiyoon generated more than 400 billion won (approximately $297.5 million) in combined revenue in fiscal 2026, up 67% year-over-year, with targets of 500 billion won in fiscal 2027 and 1 trillion won by fiscal 2030. Amorepacific also plans further overseas expansion for Aestura and Illiyoon, Sephora entry in the United States and subsequent European expansion for IOPE, and 1 trillion won in fiscal 2030 hair-care revenue with a 14–15% operating margin. For fiscal 2027, it targets 10% consolidated revenue growth and an 11–12% operating margin, alongside regional growth of 20% in North America and 30% in EMEA and Japan. Hana Securities maintained a Buy rating and a 170,000 won (approximately $130) target price, while Amorepacific said digital channels, consumer data, and market-specific insights would support growth.